Production (Stage)
Brainstorm Cell Therapeutics Inc.
BCLI
$1.23
-$0.01-0.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.64M | 187.00K | 168.00K | 3.47M | 779.00K |
| Total Receivables | 67.00K | 63.00K | 40.00K | 33.00K | 26.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 621.00K | 135.00K | 156.00K | 314.00K | 454.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.33M | 385.00K | 364.00K | 3.82M | 1.26M |
|
|
|||||
| Total Current Assets | 2.33M | 385.00K | 364.00K | 3.82M | 1.26M |
| Net Property, Plant & Equipment | 1.04M | 1.24M | 1.46M | 1.67M | 1.89M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | 0.00 | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 204.00K | 206.00K | 203.00K | 199.00K | 202.00K |
| Total Assets | 3.57M | 1.83M | 2.03M | 5.68M | 3.35M |
|
|
|||||
| Total Accounts Payable | 6.80M | 6.08M | 4.60M | 5.34M | 4.69M |
| Total Accrued Expenses | 538.00K | 619.00K | 865.00K | 718.00K | 636.00K |
| Short-term Debt | 1.20M | 300.00K | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 443.00K | 549.00K | 570.00K | 566.00K | 588.00K |
| Total Finance Division Other Current Liabilities | 1.92M | 1.43M | 1.04M | 1.07M | 917.00K |
| Total Other Current Liabilities | 1.92M | 1.43M | 1.04M | 1.07M | 917.00K |
| Total Current Liabilities | 10.90M | 8.98M | 7.08M | 7.69M | 6.83M |
|
|
|||||
| Total Current Liabilities | 10.90M | 8.98M | 7.08M | 7.69M | 6.83M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.20M | 300.00K | -- | -- | -- |
| Capital Leases | 127.00K | 171.00K | 271.00K | 396.00K | 533.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 447.00K | 729.00K | 1.12M | 1.53M |
| Total Liabilities | 11.03M | 9.60M | 8.08M | 9.21M | 8.90M |
|
|
|||||
| Common Stock & APIC | 222.16M | 218.99M | 217.72M | 217.54M | 212.98M |
| Retained Earnings | -229.50M | -226.64M | -223.66M | -220.96M | -218.41M |
| Treasury Stock & Other | -116.00K | -116.00K | -116.00K | -116.00K | -116.00K |
| Total Common Equity | -7.46M | -7.76M | -6.06M | -3.53M | -5.55M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.46M | -7.76M | -6.06M | -3.53M | -5.55M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.46M | -7.76M | -6.06M | -3.53M | -5.55M |
|
|
|||||